Chris has expertise in cancer biology and management of start-ups. With Dr. Kevin Petrecca, he built a translational research program at the Montreal Neurological Institute working with industry partners on pre-clinical development for brain cancers. He was also Director of Business Development/IP strategy at a start-up specializing in smart polymer materials. He did due-diligence, developed the business model, and managed the patent portfolio.

Dr. Kevin Petrecca is the Chief of Neurosurgery and the head of the Brain Cancer research group at the Montreal Neurological Institute. A leading expert in glioblastoma, he has published 30 peer-reviewed articles, and presented his research internationally. Also he holds 2 patents related to the use of antisense oligonucleotide mediated knockdown of proteins in preventing glioma cancer cell invasion.

Dr. Leblond is an associate professor at the Department of Engineering Physics at Polytechnique Montreal where he heads the Optical Radiology Laboratory (LRO). He is also adjunct professor at Dartmouth College, and a researcher at the Centre for Research Hospital of the University of Montreal (CHUM Research Centre).